Opko Health, Inc. License Agreements
12 Contracts & Agreements
- License Agreement by and among EirGen Pharma Limited and Nicoya Macua Limited, dated June 18, 2021 (Filed With SEC on July 29, 2021)
- Exclusive License Agreement by and between OPKO Health, Inc. and CAMP4 Therapeutics Corporation, dated July 6, 2021 (Filed With SEC on July 29, 2021)
- Amendment to Development and License Agreement between EirGen Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma Ltd., dated May 5, 2020 (Filed With SEC on July 31, 2020)
- Development and License Agreement by and between EirGen Pharma Limited, a subsidiary of OPKO Health, Inc., and Japan Tobacco Inc., dated October 12, 2017 (Filed With SEC on March 1, 2018)
- DEVELOPMENT AND LICENSE AGREEMENT BETWEEN OPKO HEALTH, INC. AND VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD May 8, 2016 (Filed With SEC on August 8, 2016)
- *** = Portions of this exhibit have been omitted pursuant to a request for confidential treatment. An unredacted version of this exhibit has been filed separately with the... (Filed With SEC on February 27, 2015)
- TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on April 2, 2007)
- LICENSE AGREEMENT (Filed With SEC on April 2, 2007)
- AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on April 2, 2007)
- AMENDMENT NO. 2 TO LICENSE AGREEMENT (Filed With SEC on April 2, 2007)
- First Amendment to the License Agreement between the The Trustees of the University of Pennsylvania and Acuity Pharmaceuticals, Inc. (Filed With SEC on April 2, 2007)
- FirstAmendment to the License Agreement between the The Trustees of the University of Pennsylvania and Acuity Pharmaceuticals, Inc. (Filed With SEC on April 2, 2007)
